JPS584773A - ピリダジノン誘導体 - Google Patents
ピリダジノン誘導体Info
- Publication number
- JPS584773A JPS584773A JP7712481A JP7712481A JPS584773A JP S584773 A JPS584773 A JP S584773A JP 7712481 A JP7712481 A JP 7712481A JP 7712481 A JP7712481 A JP 7712481A JP S584773 A JPS584773 A JP S584773A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- general formula
- derivative
- represented
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title claims description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 150000001412 amines Chemical class 0.000 claims abstract description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 6
- 150000002541 isothioureas Chemical class 0.000 claims abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- -1 amine compound Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 43
- 239000002904 solvent Substances 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 14
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 5
- 238000010992 reflux Methods 0.000 abstract description 5
- 208000008469 Peptic Ulcer Diseases 0.000 abstract description 4
- 208000011906 peptic ulcer disease Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000013078 crystal Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000001819 mass spectrum Methods 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 101100460385 Caenorhabditis elegans nhx-2 gene Proteins 0.000 description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- CEAJFNBWKBTRQE-UHFFFAOYSA-N methanamine;methanol Chemical compound NC.OC CEAJFNBWKBTRQE-UHFFFAOYSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- APLNAFMUEHKRLM-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)N=CN2 APLNAFMUEHKRLM-UHFFFAOYSA-N 0.000 description 1
- 101100460384 Arabidopsis thaliana NHX2 gene Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101000697856 Rattus norvegicus Bile acid-CoA:amino acid N-acyltransferase Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GMEGXJPUFRVCPX-UHFFFAOYSA-N butylthiourea Chemical compound CCCCNC(N)=S GMEGXJPUFRVCPX-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7712481A JPS584773A (ja) | 1981-05-20 | 1981-05-20 | ピリダジノン誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7712481A JPS584773A (ja) | 1981-05-20 | 1981-05-20 | ピリダジノン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS584773A true JPS584773A (ja) | 1983-01-11 |
| JPH0143750B2 JPH0143750B2 (enrdf_load_html_response) | 1989-09-22 |
Family
ID=13625040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7712481A Granted JPS584773A (ja) | 1981-05-20 | 1981-05-20 | ピリダジノン誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS584773A (enrdf_load_html_response) |
-
1981
- 1981-05-20 JP JP7712481A patent/JPS584773A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0143750B2 (enrdf_load_html_response) | 1989-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1136623A (en) | Amino-pyrimidine-carbanilides, processes for their preparation, medicaments containing these compounds and their use and also diamino-pyrimidinecarbanilides and processes for their preparation | |
| ATE19513T1 (de) | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
| SU1296006A3 (ru) | Способ получени дигидропиридинов | |
| ATE26716T1 (de) | 2-(haloergolinyl)-n'n'-diaethylharnstoff-derivat , verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| PT73338B (en) | 3,1-benzoxazin-2-one ihre herstellung und verwendung | |
| GB1572976A (en) | Process for the production of uea derivatives | |
| US3498981A (en) | Substituted as-triazines | |
| ES8703481A1 (es) | Un procedimiento para la preparacion de fosfatidos de eter de glicol | |
| JPS584773A (ja) | ピリダジノン誘導体 | |
| DK142766B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 8-azapurin-6-on-derivater. | |
| KR840001953B1 (ko) | 벤조구아나민 유도체의 제조법 | |
| DE2965377D1 (en) | 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them | |
| ATE42555T1 (de) | Neue sulfonyl(thio)harnstoffe, verfahren zu deren herstellung und deren verwendung als herbizide und/oder wachstumsregulatoren. | |
| ES8406999A1 (es) | Procedimiento para la obtencion de 2-halogenopropionatos sustituidos. | |
| Banks et al. | Fluorocarbon derivatives of nitrogen. Part 13. Reaction of perfluoroalkanenitriles with pyridinium alkoxycarbonylmethylides: synthesis of perfluoroalkylated imidazo [1, 2-a] pyridines (1-azaindolizines). X-Ray molecular structure of pyridinium 4, 5-dihydro-4-oxo-2, 6-bis (trifluoromethyl) pyrimidin-5-ylide | |
| ES8306733A1 (es) | Derivados de anilina y sus sales. | |
| ATE42295T1 (de) | Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen. | |
| ATE15204T1 (de) | Derivate der 2-nitro-4- oder 5-pyridyloxyphenylphosphons|ure, verfahren zu ihrer herstellung, ihre verwendung als herbizide und/oder pflanzenwachstumsregulatoren und/oder mikrobizide, sowie zur herstellung der derivate verwendete zwischenprodukte, verfahren zu deren herstellung und deren verwendung als herbizide. | |
| PT78362B (de) | Pyrimidin-thioalkylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| Soma et al. | Studies on Seven-membered Ring Compounds. XIX. Reactions of Troponeimine Derivatives.(1) | |
| AT238200B (de) | Verfahren zur Herstellung von neuen Pyridinderivaten | |
| CA1312611C (en) | Pyridine derivatives, process for production thereof and pharmaceutical composition containing them | |
| ES8403878A1 (es) | Procedimiento para la obtencion de derivados de tetrahicro-2 pirimidona metil-sustituidos. | |
| CA1060011A (en) | Pyridazinium compounds and a process for their production | |
| ES485973A1 (es) | Un procedimiento de preparacion de nuevos derivados de amino-3-sulfamido-6-(1h,3h)-quinazolin-dionas-2,4 |